Schaub James 4
4 · Osmotica Pharmaceuticals plc · Filed May 20, 2020
Insider Transaction Report
Form 4
Schaub James
EVP and COO
Transactions
- Award
Ordinary Shares
2020-05-18+73,253→ 328,408 total - Award
Performance-Based Restricted Stock Units
2020-05-18+73,253→ 73,253 total→ Ordinary Shares (73,253 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units.
- [F2]The performance-based restricted stock units represent a contingent right to receive, upon vesting, a varying number of the registrant's ordinary shares based on certain pre-determined thresholds for the closing price of registrant's ordinary shares on the Nasdaq Global Select Market. The performance-based restricted stock units vest on the third anniversary of the date of grant and, upon vesting, will convert into 0%, 50%, 100% or 150% of the target number of ordinary shares listed in Column 7 of Table II.